Intrance Medical Systems
Intrance Medical Systems Inc., a subsidiary of Sweden-based Intrance Holdings AB, is a private biopharmaceutical company focused on the development and commercialization of its lead clinical product for the treatment of advanced Parkinson’s disease in the U.S., Canada, Mexico, South America, Japan and Taiwan.
Intrance Medical Systems has raised €6.8M across 1 funding round from 1 investor, most recently a round in Sep 2021. Based in Stockholm, Sweden; active in Healthtech. Data as of 28 Oct 2026.
Stockholm, Swedenwww.intrancemedical.com ↗
Total raised
€6.8M
€6,831,184
Funding rounds
1
Investors
1
distinct backers
Active since
2021-09
latest 2021-09
Funding by year
EUR raised per yearIntrance Medical Systems — funding by year — interactive chart.
Data table
| Intrance Medical Systems — funding by year | |
|---|---|
| 2021 | €6.8M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-09-20 | Other | €6.8M | Erik Selin Fastigheter | View deal → |